Lv1
40 积分 2024-10-22 加入
Use of BCMA Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Versus BCMA T-Cell Engagers in BCMA-Exposed Relapsed/Refractory Multiple Myeloma
9小时前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
11小时前
已完结
Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus
6个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
9个月前
已完结
皖公网安备34019202002308
